Table III.

DHI of female patients with Meniere's disease.

DHI	Baseline (T0)	3 months (T1)	6 months (T2)	P-valuea (T1 vs. T0)	P-valuea (T2 vs. T0)	P-valuea (T2 vs. T1)
Group A	72.3±3.7	47.5±3.7	43.4±3.4	0.001	0.001	0.001
Group B	70.6±3.9	64.2±3.3	58.5±3.1	0.010	0.001	0.004
P-valueb	0.077	0.001	0.001

^aPaired Student's t-test;

^bTwo-sided t-test for independent samples by ANOVA. Intra- and intergroup statistical evaluation of female patients treated with 2 mg drospirenone and 1 mg 17β-estradiol hormone therapy combined with rehabilitation (group A), or rehabilitation alone (group B), for 3 (T1) and 6 (T2) months. DHI, Dizziness Handicap Inventory.